Expression of RPL26 in testis cancer - The Human Protein Atlas

TESTICULAR GERM CELL TUMOR (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL26 is not prognostic in Testicular Germ Cell Tumor (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 4493.56

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

5-year survival highⁱ N/A

5-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

4046.0

Number of samples

133

Samples

Sample	Description	pTPM
TCGA-2G-AAGF-01A	28 years, male, white, stage:Stage IS, alive, 2734 days	10917.7
TCGA-2G-AAKD-01A	18 years, male, white, stage:Stage III, alive, 6340 days	10027.6
TCGA-XE-AANR-01A	23 years, male, white, stage:Stage I, alive, 14 days	9008.2
TCGA-S6-A8JX-01A	27 years, male, white, stage:Stage IB, alive, 552 days	8352.2
TCGA-2G-AAKL-01A	26 years, male, white, stage:Stage II, alive, 7023 days	7792.1
TCGA-2G-AAF6-01A	28 years, male, white, stage:Stage IS, alive, 3491 days	7368.7
TCGA-2G-AAHC-01A	33 years, male, white, stage:Stage IS, alive, 5539 days	6576.5
TCGA-VF-A8AC-01A	29 years, male, white, stage:Stage IA, alive, 1083 days	6538.4
TCGA-2G-AAGW-01A	38 years, male, white, stage:Stage IS, alive, 4899 days	6226.5
TCGA-2G-AAGZ-01A	27 years, male, white, stage:Stage IIIA, alive, 5233 days	6098.5
TCGA-XE-AAO3-01A	33 years, male, asian, stage:Stage I, alive, 2857 days	6086.4
TCGA-2G-AAFM-01A	31 years, male, white, stage:Stage IIA, alive, 503 days	6050.2
TCGA-4K-AA1I-01A	26 years, male, white, stage:Stage IA, alive, 3 days	6036.8
TCGA-2G-AAF8-01A	33 years, male, white, stage:Stage IA, alive, 3911 days	5920.0
TCGA-2G-AAKG-01A	22 years, male, white, stage:Stage I, alive, 6598 days	5827.8
TCGA-2G-AAGA-01A	38 years, male, white, stage:Stage IIA, alive, 2439 days	5778.4
TCGA-2G-AAHL-01A	26 years, male, white, stage:Stage I, alive, 7081 days	5724.1
TCGA-2G-AAKH-01A	19 years, male, white, stage:Stage II, alive, 6862 days	5636.4
TCGA-2G-AAHG-01A	25 years, male, white, stage:Stage I, alive, 1819 days	5626.1
TCGA-2G-AAFG-01A	30 years, male, white, stage:Stage IS, alive, 6183 days	5572.1
TCGA-VF-A8A8-01A	18 years, male, white, stage:Stage IA, alive, 1131 days	5417.3
TCGA-2G-AAEW-01A	31 years, male, white, stage:Stage IS, dead, 618 days	5397.0
TCGA-2G-AAL7-01A	32 years, male, white, stage:Stage IS, alive, 3991 days	5384.2
TCGA-2G-AAGJ-01A	28 years, male, black or african american, stage:Stage IA, alive, 2938 days	5345.7
TCGA-2G-AAH3-01A	20 years, male, white, stage:Stage I, alive, 1822 days	5227.4
TCGA-2G-AAFI-01A	41 years, male, white, stage:Stage IB, alive, 675 days	5204.4
TCGA-2G-AAFN-01A	26 years, male, white, stage:Stage IIIB, alive, 773 days	5200.6
TCGA-2G-AAGC-01A	28 years, male, white, stage:Stage IS, alive, 2585 days	5196.9
TCGA-XE-AAOD-01A	39 years, male, white, stage:Stage IB, alive, 2058 days	5185.5
TCGA-YU-A90Q-01A	21 years, male, stage:Stage IB, alive, 1964 days	5159.2
TCGA-VF-A8AD-01A	36 years, male, white, stage:Stage IB, alive, 1006 days	5146.6
TCGA-2G-AAHP-01A	31 years, male, white, stage:Stage IS, alive, 5667 days	5071.2
TCGA-S6-A8JW-01A	37 years, male, white, stage:Stage IS, alive, 698 days	4985.0
TCGA-2G-AAFE-01A	37 years, male, white, stage:Stage IIA, alive, 4702 days	4971.3
TCGA-2G-AAFO-01A	33 years, male, white, stage:Stage IIA, alive, 685 days	4969.2
TCGA-W4-A7U4-01A	23 years, male, white, stage:'--, alive, 738 days	4943.1
TCGA-XE-A8H1-01A	24 years, male, white, stage:Stage IS, alive, 209 days	4894.5
TCGA-VF-A8AA-01A	51 years, male, white, stage:Stage I, alive, 1146 days	4803.2
TCGA-2G-AAKM-01A	14 years, male, white, stage:Stage II, dead, 6972 days	4739.7
TCGA-2G-AAF4-01A	30 years, male, white, stage:Stage I, alive, 2315 days	4719.2
TCGA-2G-AAHA-01A	48 years, male, white, stage:Stage IB, alive, 3349 days	4530.9
TCGA-YU-A90Y-01A	23 years, male, black or african american, stage:Stage IIIC, dead, 17 days	4498.0
TCGA-XE-AANV-01A	52 years, male, stage:Stage IB, alive, 1701 days	4489.1
TCGA-4K-AA1G-01A	34 years, male, white, stage:Stage IS, alive, 436 days	4450.5
TCGA-XE-AAO6-01A	47 years, male, white, stage:Stage IA, alive, 240 days	4440.1
TCGA-SO-A8JP-01A	29 years, male, white, stage:Stage I, alive, 540 days	4396.9
TCGA-YU-A94D-01A	28 years, male, stage:Stage IIIB, alive, 2167 days	4348.4
TCGA-2G-AAH8-01A	45 years, male, white, stage:Stage IIIC, alive, 2248 days	4325.1
TCGA-XE-AANJ-01A	39 years, male, white, stage:Stage IS, alive, 2007 days	4311.2
TCGA-2G-AAHN-01A	32 years, male, white, stage:Stage I, alive, 6445 days	4275.2
TCGA-2G-AAGK-01A	20 years, male, white, stage:Stage IS, alive, 3621 days	4259.5
TCGA-W4-A7U2-01A	26 years, male, white, stage:'--, alive, 1263 days	4256.6
TCGA-2G-AAG3-01A	53 years, male, white, stage:Stage IS, alive, 1593 days	4172.7
TCGA-2G-AAFZ-01A	32 years, male, white, stage:Stage III, alive, 1353 days	4103.2
TCGA-YU-A90W-01A	45 years, male, white, stage:Stage IA, alive, 1113 days	4089.2
TCGA-SB-A76C-01A	38 years, male, white, stage:'--, alive, 42 days	4071.7
TCGA-2G-AAG5-01A	36 years, male, white, stage:Stage IS, alive, 2299 days	4064.9
TCGA-S6-A8JY-01A	27 years, male, white, stage:Stage IS, alive, 278 days	4056.4
TCGA-YU-A90S-01A	26 years, male, white, stage:Stage IA, alive, 971 days	4045.2
TCGA-XE-A8H4-01A	23 years, male, white, stage:Stage IA, alive, 559 days	4036.9
TCGA-WZ-A8D5-01A	38 years, male, white, stage:'--, alive, 774 days	4022.0
TCGA-2G-AAGN-01A	41 years, male, white, stage:Stage IIIB, alive, 3656 days	4020.4
TCGA-SN-A84X-01A	21 years, male, white, stage:Stage IS, alive, 312 days	4012.5
TCGA-2G-AAL5-01A	31 years, male, white, stage:Stage I, alive, 7437 days	4010.1
TCGA-2G-AAGM-01A	51 years, male, white, stage:Stage IS, alive, 3891 days	3951.4
TCGA-XE-A8H5-01A	29 years, male, stage:Stage IS, alive, 1217 days	3913.4
TCGA-WZ-A7V5-01A	27 years, male, white, stage:Stage I, alive, 1061 days	3883.6
TCGA-2G-AAF1-01A	28 years, male, asian, stage:Stage IS, alive, 1403 days	3859.7
TCGA-2G-AAG0-01A	23 years, male, white, stage:Stage IS, alive, 1529 days	3842.2
TCGA-VF-A8A9-01A	31 years, male, white, stage:Stage IA, alive, 1119 days	3841.8
TCGA-2G-AAH0-01A	30 years, male, white, stage:Stage IS, alive, 5477 days	3824.0
TCGA-VF-A8AE-01A	39 years, male, white, stage:Stage IA, alive, 727 days	3729.2
TCGA-2G-AAGI-01A	33 years, male, white, stage:Stage IS, alive, 3137 days	3720.0
TCGA-WZ-A7V3-01A	20 years, male, white, stage:Stage I, alive, 753 days	3713.4
TCGA-SB-A6J6-01A	22 years, male, white, stage:Stage IA, alive, 413 days	3687.0
TCGA-YU-A90P-01A	25 years, male, white, stage:Stage IA, alive, 2069 days	3670.5
TCGA-2G-AALP-01A	43 years, male, white, stage:Stage IIIB, alive, 2645 days	3666.5
TCGA-4K-AA1H-01A	26 years, male, white, stage:Stage IA, alive, 518 days	3644.1
TCGA-2G-AAGO-01A	41 years, male, white, stage:Stage IS, alive, 4026 days	3639.8
TCGA-2G-AAEX-01A	38 years, male, white, stage:Stage IS, alive, 1259 days	3597.1
TCGA-2G-AAFY-01A	24 years, male, white, stage:Stage IIA, alive, 1099 days	3546.9
TCGA-XE-AAOJ-01A	24 years, male, white, stage:Stage IS, alive, 1550 days	3474.1
TCGA-2G-AAGT-01A	30 years, male, white, stage:Stage IS, alive, 4406 days	3449.5
TCGA-2G-AAFV-01A	31 years, male, white, stage:Stage IS, alive, 1389 days	3426.8
TCGA-YU-AA4L-01A	27 years, male, black or african american, stage:Stage IIIC, alive, 1573 days	3415.8
TCGA-4K-AAAL-01A	31 years, male, white, stage:Stage IS, alive, 483 days	3384.7
TCGA-2G-AAG9-01A	25 years, male, white, stage:Stage IIIB, alive, 2234 days	3373.8
TCGA-SN-A84Y-01A	18 years, male, white, stage:Stage IS, alive, 524 days	3252.7
TCGA-VF-A8AB-01A	31 years, male, black or african american, stage:Stage IA, alive, 760 days	3216.7
TCGA-2X-A9D6-01A	42 years, male, white, stage:Stage I, alive, 607 days	3188.9
TCGA-SN-A84W-01A	30 years, male, white, stage:Stage IS, alive, 293 days	3171.0
TCGA-XE-AAOC-01A	31 years, male, white, stage:Stage IA, alive, 270 days	3159.2
TCGA-2G-AAGS-01A	39 years, male, white, stage:Stage IIIB, alive, 4816 days	3112.2
TCGA-2G-AAG6-01A	24 years, male, white, stage:Stage IS, alive, 2231 days	3093.6
TCGA-XE-AAO4-01A	40 years, male, white, stage:Stage IA, alive, 367 days	3061.8
TCGA-2G-AAGG-01A	20 years, male, white, stage:Stage IIIC, alive, 2611 days	3053.0
TCGA-2G-AAH4-01A	34 years, male, white, stage:Stage II, alive, 6210 days	3033.0
TCGA-2G-AAFJ-01A	23 years, male, asian, stage:'--, alive, 792 days	3025.4
TCGA-2G-AAH2-01A	20 years, male, white, stage:Stage IS, alive, 6060 days	2938.2
TCGA-XE-AAOF-01A	50 years, male, asian, stage:Stage IA, alive, 1268 days	2935.5
TCGA-2G-AAGE-01A	21 years, male, white, stage:Stage IS, alive, 2478 days	2932.4
TCGA-2G-AAFL-01A	35 years, male, white, stage:Stage IB, alive, 750 days	2909.1
TCGA-YU-A912-01A	34 years, male, black or african american, stage:Stage IIIC, alive, 866 days	2873.7
TCGA-YU-AA61-01A	29 years, male, white, stage:Stage IS, alive, 864 days	2872.9
TCGA-2G-AAG8-01A	21 years, male, white, stage:Stage IB, alive, 2289 days	2856.5
TCGA-WZ-A7V4-01A	28 years, male, white, stage:Stage I, alive, 894 days	2823.6
TCGA-2G-AAGX-01A	22 years, male, white, stage:Stage IA, alive, 5514 days	2738.8
TCGA-2G-AAGV-01A	23 years, male, white, stage:'--, alive, 4527 days	2730.9
TCGA-XE-AAOL-01A	38 years, male, black or african american, stage:Stage I, alive, 13 days	2727.6
TCGA-XY-A8S2-01A	67 years, male, white, stage:Stage I, alive, 672 days	2694.1
TCGA-YU-A94I-01A	66 years, male, stage:Stage IA, alive, 536 days	2532.1
TCGA-2G-AAG7-01A	33 years, male, white, stage:Stage IS, alive, 2475 days	2484.9
TCGA-2G-AAGY-01A	28 years, male, white, stage:Stage IS, alive, 5329 days	2468.4
TCGA-2G-AAFH-01A	38 years, male, white, stage:Stage IIB, alive, 1375 days	2432.1
TCGA-ZM-AA0E-01A	39 years, male, white, stage:Stage IA, alive, 811 days	2260.1
TCGA-2X-A9D5-01A	49 years, male, white, stage:Stage I, alive, 435 days	2256.1
TCGA-ZM-AA0D-01A	34 years, male, white, stage:Stage IA, alive, 848 days	2232.7
TCGA-XE-A9SE-01A	35 years, male, white, stage:Stage IA, alive, 708 days	2144.6
TCGA-SN-A6IS-01A	26 years, male, white, stage:Stage IS, alive, 496 days	2131.5
TCGA-XE-AANI-01A	37 years, male, white, stage:Stage IS, alive, 1041 days	2129.3
TCGA-ZM-AA0B-01A	32 years, male, white, stage:Stage IA, alive, 838 days	2094.5
TCGA-XY-A89B-01A	35 years, male, white, stage:Stage IA, alive, 471 days	1989.9
TCGA-X3-A8G4-01A	33 years, male, white, stage:Stage IS, alive, 856 days	1909.2
TCGA-2G-AAHT-01A	32 years, male, white, stage:Stage IS, alive, 542 days	1873.6
TCGA-ZM-AA0H-01A	50 years, male, white, stage:Stage IS, alive, 1736 days	1860.8
TCGA-W4-A7U3-01A	26 years, male, white, stage:'--, alive, 149 days	1857.3
TCGA-2G-AAGP-01A	33 years, male, white, stage:Stage IIA, alive, 4018 days	1831.9
TCGA-ZM-AA06-01A	45 years, male, white, stage:Stage IB, alive, 1498 days	1789.8
TCGA-XE-AAOB-01A	27 years, male, white, stage:Stage IS, dead, 513 days	1556.7
TCGA-XY-A9T9-01A	37 years, male, white, stage:Stage IS, alive, 281 days	1514.7
TCGA-ZM-AA0F-01A	35 years, male, white, stage:Stage IA, alive, 681 days	1423.6
TCGA-ZM-AA05-01A	36 years, male, white, stage:Stage IIC, alive, 1126 days	1151.6
TCGA-ZM-AA0N-01A	44 years, male, white, stage:Stage IB, alive, 634 days	1132.7
Show allShow less

TESTIS CANCER - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA030449	Antibody CAB037301
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Carcinoma, Embryonal, NOS
Seminoma, NOS
Seminoma, NOS Carcinoma, Embryonal, NOS